UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 396

Sortiert nach

Epidemiology of severe sepsis

Virulence, 2014-01, Vol.5 (1), p.4-11

2014

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

Annals of internal medicine, 2021-10, Vol.174 (10), p.1404

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)

Critical care medicine, 2019-05, Vol.47 (5), p.632

2019

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans

The New England journal of medicine, 2022-04, Vol.386 (14), p.1375-1377

2022

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Lin28-mediated miRNA and mRNA regulation--a structural and functional perspective

International Journal of Molecular Sciences, 2013-08, Vol.14 (8), p.16532-16553

2013

Link zum Volltext

Verfügbarkeit prüfen

Three Decades of Sepsis in the United Kingdom: Tracing the Tides of Time

American journal of respiratory and critical care medicine, 2024-03, Vol.209 (5), p.468

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

Intensive care medicine, 2019-10, Vol.45 (10), p.1360-1371

2019

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods

Nature communications, 2022-06, Vol.13 (1), p.3647-3647, Article 3647

2022

Link zum Volltext

Verfügbarkeit prüfen

Size matters! Peripheral blood leukocyte telomere length and survival after critical illness

The European respiratory journal, 2020-01, Vol.55 (1), p.1902114

2020

Link zum Volltext

Verfügbarkeit prüfen

Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e849-e856

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying Survivors of Sepsis at Risk for Adverse Cardiovascular Outcomes

American journal of respiratory and critical care medicine, 2021-09, Vol.204 (5), p.500-501

2021

Link zum Volltext

Verfügbarkeit prüfen

Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant

Clinical infectious diseases, 2022-12, Vol.75 (12), p.2161-2168

2022

Link zum Volltext

Verfügbarkeit prüfen

Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions

JAMA : the journal of the American Medical Association, 2017-02, Vol.317 (5), p.530

2017

Link zum Volltext

Verfügbarkeit prüfen

Reply to Wirth et al

Clinical infectious diseases, 2023-01, Vol.76 (1), p.177-178

2023

Link zum Volltext

Verfügbarkeit prüfen

Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis

JAMA : the journal of the American Medical Association, 2010-06, Vol.303 (24), p.2495

2010

Link zum Volltext

Verfügbarkeit prüfen

Very long-term survivors of in-hospital and out-of-hospital cardiac arrest show considerable impairment of daily life

Resuscitation, 2022-04, Vol.173, p.192-200

2022

Link zum Volltext

Verfügbarkeit prüfen

Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e579-e584

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e617-e622

2022

Link zum Volltext

Verfügbarkeit prüfen

Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19

The Journal of infectious diseases, 2023-10, Vol.228 (8), p.1033-1041

2023

Link zum Volltext

Verfügbarkeit prüfen

Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study

The Journal of infectious diseases, 2024-01, Vol.229 (1), p.147-154

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: A prospective observational study (Ubon-sepsis)

PloS one, 2018-09, Vol.13 (9), p.e0204509-e0204509

2018

Link zum Volltext

Verfügbarkeit prüfen

Understanding the complex host response in sepsis: is diabetes the key?

Critical care (London, England), 2016-10, Vol.20 (1), p.321-321, Article 321

2016

Link zum Volltext

Verfügbarkeit prüfen

The Lin28 cold-shock domain remodels pre-let-7 microRNA

Nucleic acids research, 2012-08, Vol.40 (15), p.7492

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population

EClinicalMedicine, 2021-10, Vol.40, p.101117-101117, Article 101117

2021

Link zum Volltext

Verfügbarkeit prüfen

Children with Chronic Disease Bear the Highest Burden of Pediatric Sepsis

The Journal of pediatrics, 2018-08, Vol.199, p.194-199.e1

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 396

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(340)
Mit Volltextzugriff
(354)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(367)
Japanisch
(45)
Deutsch
(30)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Epidemiology of severe sepsis

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans

Mechanisms of Lin28-mediated miRNA and mRNA regulation--a structural and functional perspective

Three Decades of Sepsis in the United Kingdom: Tracing the Tides of Time

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods

Size matters! Peripheral blood leukocyte telomere length and survival after critical illness

Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population

Identifying Survivors of Sepsis at Risk for Adverse Cardiovascular Outcomes

Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant

Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions

Reply to Wirth et al

Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis

Very long-term survivors of in-hospital and out-of-hospital cardiac arrest show considerable impairment of daily life

Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population

Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis

Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19

Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study

Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: A prospective observational study (Ubon-sepsis)

Understanding the complex host response in sepsis: is diabetes the key?

The Lin28 cold-shock domain remodels pre-let-7 microRNA

Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population

Children with Chronic Disease Bear the Highest Burden of Pediatric Sepsis

Suchergebnisse filtern